文献速递血栓与止血

儿童患者的止血与血栓性疾病

Hemostatic and thrombotic disorders in the pediatric patient.
PubMed 文献 · Blood · 2022-01-01

本文综述近十年儿童止血与血栓领域的重要进展,涵盖出血评估工具、血管性血友病实验室检查、血友病治疗新范式、儿童静脉血栓栓塞症的直接口服抗凝药临床试验、血栓预防及风险预测模型,并指出仍有许多未解问题。

要点

  • 儿童出血评估工具已获验证,血管性血友病实验室检查有进展,显著出血表型患者凝血检查正常需重新解读。
  • 血友病治疗出现新范式,患有出血性疾病的女性多学科医疗之家兴起。
  • 儿童静脉血栓栓塞症需全面应对,直接口服抗凝药临床试验已完成,血栓预防和风险预测模型有进展。

核心结论

  • 尽管过去十年儿童止血与血栓领域取得显著进展,仍有许多未解问题留给下一代研究者。

研究设计与样本

  • 综述,聚焦过去十年内已发表的研究。

主要发现

  • 儿童出血评估工具已获验证,血管性血友病实验室检查有进展,显著出血表型患者凝血检查正常需重新解读。
  • 血友病治疗出现新范式,患有出血性疾病的女性多学科医疗之家兴起。
  • 儿童静脉血栓栓塞症发病率持续增加,尤其在医院环境中。
  • 近期完成了儿童和青少年直接口服抗凝药的临床试验,并正在研究诱发性血栓儿童适宜的治疗持续时间。
  • 血栓预防研究及医院获得性血栓风险预测模型的开发受到关注。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This review focuses on significant advances in the field of pediatric hemostasis and thrombosis, with a focus on published studies within the past decade. The evaluation and management of patients with excessive bleeding remain cornerstones of consultative hematology. We will describe the development of validated bleeding assessment tools relevant to pediatric practice, laboratory advances in the evaluation of von Willebrand disease, and a shift in clinical practice regarding the interpretation of normal coagulation studies in patients with significant bleeding phenotypes. There have also been critical advances in the management of hemostatic disorders. This review highlights new treatment paradigms in hemophilia and the rise of multidisciplinary medical homes for women living with bleeding disorders. Given the continued increase in the incidence of thrombosis, particularly in the hospital setting, a full call to arms against pediatric venous thromboembolism is now essential. We will describe recently completed clinical trials of direct oral anticoagulants in children and adolescents and ongoing work to elucidate the appropriate duration of therapy for children with provoked thrombosis. Recent work regarding the prevention of pediatric venous thromboembolism is highlighted, including studies of thromboprophylaxis and the development of risk prediction models for hospital-acquired thrombosis. Finally, we review advances in our understanding of thrombotic sequelae and the need for continued refinement of our evaluation tools. Despite the significant advances in pediatric hemostasis and thrombosis over the past decade, many unanswered questions remain for the next generation of investigators.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. O'Brien SH, Zia A. Hemostatic and thrombotic disorders in the pediatric patient. Blood. 2022. PMID: 34724564. doi:10.1182/blood.2020006477

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。